a Institute of Biological Sciences, Faculty of Science , University of Malaya , Kuala Lumpur , Malaysia.
b Biotropics Malaysia Berhad , Selangor , Malaysia.
Pharm Biol. 2019 Dec;57(1):145-153. doi: 10.1080/13880209.2019.1585460.
Phyllanthus amarus Schumach. and Thonn. (Euphorbiaceae) is traditionally known to improve general liver health. However, its effect on hangover is unknown.
This study evaluated PHYLLPRO™, a standardized ethanol extract of P. amarus leaves for protection against oxidative stress and recovery from hangover symptoms.
Ten days daily oral supplementation of 750 mg/day followed by intoxication was evaluated in a randomized placebo-controlled (containing only excipient), crossover study in 15 subjects (21-50 years old), for oxidative stress, liver damage, alleviating hangover symptoms (Hangover Severity Score: HSS) and mood improvement (Profile-of-Mood-Scores: POMS).
PHYLLPRO™ was able to remove blood alcohol in the active group while the placebo group still had 0.05% at 12 h post-intoxication (p < 0.0001). For HSS, the active group showed reduced hangover symptoms while there were higher levels of nausea, headache, anorexia, tremulousness, diarrhoea and dizziness in the placebo group (p < 0.05) at hour 10 post-intoxication. Increased fatigue at hour 2 and tension (p > 0.05) from baseline to hour 22 was reported in the placebo group using POMS. Significant anti-inflammatory group effect favouring the active group, by the upregulation of cytokines IL-8 (p = 0.0014) and IL-10 (p = 0.0492) and immunomodulatory effects via IL-12p70 (p = 0.0304) were observed. The incidence of adverse events was similar between groups indicating the safety of PHYLLPRO™.
Preliminary findings of PHYLLPRO™ in managing hangover, inflammation and liver functions following intoxication, is demonstrated. Future studies on PHYLLPRO™ in protecting against oxidative stress and hangover in larger populations is warranted.
叶下珠(Euphorbiaceae)被传统医学用于改善整体肝脏健康。然而,其对宿醉的影响尚不清楚。
本研究评估了 PHYLLPRO™,一种叶下珠标准化乙醇提取物,用于预防氧化应激和缓解宿醉症状。
在一项随机安慰剂对照(仅包含赋形剂)交叉研究中,15 名(21-50 岁)受试者连续 10 天每天口服 750mg/天,然后进行醉酒,评估氧化应激、肝损伤、缓解宿醉症状(宿醉严重程度评分:HSS)和改善情绪(心境剖面图评分:POMS)。
PHYLLPRO™ 可在活性组中清除血液中的酒精,而安慰剂组在醉酒后 12 小时仍有 0.05%的酒精(p<0.0001)。对于 HSS,活性组显示出宿醉症状减轻,而安慰剂组在醉酒后 10 小时出现更高水平的恶心、头痛、食欲不振、震颤、腹泻和头晕(p<0.05)。安慰剂组在醉酒后 2 小时报告疲劳增加(p>0.05),22 小时时报告紧张(p>0.05)。通过上调细胞因子 IL-8(p=0.0014)和 IL-10(p=0.0492)以及通过 IL-12p70 发挥免疫调节作用(p=0.0304),观察到显著的抗炎组效应有利于活性组。
初步研究结果表明,PHYLLPRO™ 在管理醉酒后宿醉、炎症和肝功能方面有效。未来需要更大人群研究 PHYLLPRO™ 预防氧化应激和宿醉的作用。